Madrigal Pharmaceuticals MDGL Stock
305.32 USD
{{ price }}
-2.884954%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
6.74B USD
LOW - HIGH [24H]
290.5
-
321.59 USD
VOLUME [24H]
185.77K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-21.91 USD
Madrigal Pharmaceuticals Price Chart
Madrigal Pharmaceuticals MDGL Financial and Trading Overview
| Madrigal Pharmaceuticals stock price | 305.32 USD |
| Previous Close | 256.71 USD |
| Open | 255 USD |
| Bid | 0 USD x 1000 |
| Ask | 0 USD x 800 |
| Day's Range | 251.59 - 257.87 USD |
| 52 Week Range | 57.21 - 322.67 USD |
| Volume | 208.71K USD |
| Avg. Volume | 344.97K USD |
| Market Cap | 4.67B USD |
| Beta (5Y Monthly) | -0.705281 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -21.91 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 331.17 USD |
MDGL Valuation Measures
| Enterprise Value | 4.45B USD |
| Trailing P/E | N/A |
| Forward P/E | -22.733986 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 31.11666 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -14.18 |
Trading Information
Madrigal Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | -0.705281 |
| 52-Week Change | 263.43% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 322.67 USD |
| 52 Week Low | 57.21 USD |
| 50-Day Moving Average | 279.59 USD |
| 200-Day Moving Average | 195.32 USD |
MDGL Share Statistics
| Avg. Volume (3 month) | 344.97K USD |
| Avg. Daily Volume (10-Days) | 251.76K USD |
| Shares Outstanding | 18.29M |
| Float | 10.35M |
| Short Ratio | 4.25 |
| % Held by Insiders | 17.67% |
| % Held by Institutions | 85.41% |
| Shares Short | 1.45M |
| Short % of Float | 9.68% |
| Short % of Shares Outstanding | 7.93% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:35 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -70.77% |
| Return on Equity (ttm) | -212.74% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -313836000 USD |
| Net Income Avi to Common (ttm) | -314728000 USD |
| Diluted EPS (ttm) | -17.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 329.48M USD |
| Total Cash Per Share (mrq) | 18.02 USD |
| Total Debt (mrq) | 84.62M USD |
| Total Debt/Equity (mrq) | 56.36 USD |
| Current Ratio (mrq) | 3.368 |
| Book Value Per Share (mrq) | 8.212 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -259011008 USD |
| Levered Free Cash Flow (ttm) | -142592496 USD |
Profile of Madrigal Pharmaceuticals
| Country | United States |
| State | PA |
| City | West Conshohocken |
| Address | Four Tower Bridge |
| ZIP | 19428 |
| Phone | 267 824 2827 |
| Website | https://www.madrigalpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 92 |
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor beta agonist, which is in Phase III clinical trials for treating NASH. The company is also developing MGL-3745, a backup compound to resmetirom. The company is headquartered in West Conshohocken, Pennsylvania.
Q&A For Madrigal Pharmaceuticals Stock
What is a current MDGL stock price?
Madrigal Pharmaceuticals MDGL stock price today per share is 305.32 USD.
How to purchase Madrigal Pharmaceuticals stock?
You can buy MDGL shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Madrigal Pharmaceuticals?
The stock symbol or ticker of Madrigal Pharmaceuticals is MDGL.
Which industry does the Madrigal Pharmaceuticals company belong to?
The Madrigal Pharmaceuticals industry is Biotechnology.
How many shares does Madrigal Pharmaceuticals have in circulation?
The max supply of Madrigal Pharmaceuticals shares is 22.08M.
What is Madrigal Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Madrigal Pharmaceuticals PE Ratio is now.
What was Madrigal Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Madrigal Pharmaceuticals EPS is -21.91 USD over the trailing 12 months.
Which sector does the Madrigal Pharmaceuticals company belong to?
The Madrigal Pharmaceuticals sector is Healthcare.
Madrigal Pharmaceuticals MDGL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 15404.92 USD — |
-1.17
|
5.29B USD — | 14784.03 USD — | 16292.28 USD — | — - | 5.29B USD — |
| NASDAQ Capital Market Composite RCMP | 91.39 USD — |
-0.84
|
— — | 86.91 USD — | 95.14 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7558.05 USD — |
-0.89
|
— — | 7233.89 USD — | 7972.89 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 3824.94 USD — |
-2.03
|
— — | 3700.88 USD — | 3966.57 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 858.4 USD — |
-1.31
|
— — | 828.4 USD — | 890 USD — | — - | — — |
- {{ link.label }} {{link}}